Related Experiment Video
Updated: Sep 7, 2025

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
YTHDF3 Facilitates eIF2AK2 and eIF3A Recruitment on mRNAs to Regulate Translational Processes in
Yang Zhao1,2, Hongchao Zhao3, Danhuan Zhang4
1Department of Pathology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
Abstract:
Oxaliplatin, as a first-line drug, frequently causes chemo-resistance in colorectal cancer (CRC). The role of N6-methyladenosine (m6A) modification in multiple biological functions has been well studied. However, the molecular mechanisms underlying m6A methylation in modulating anti-cancer drug resistance in CRC remain obscure. In the present study, we found that YTH m6A RNA-binding protein 3 (YTHDF3) was highly expressed in oxaliplatin-resistant (OXAR) CRC tissues and cells. Moreover, we observed that YTHDF3 could recognize the 5' untranslated region of significantly m6A-methylated RNAs, which were associated with tumor resistance and recruit eukaryotic translation initiation factor 3 subunit A (eIF3A) to facilitate the translation of these target genes. Furthermore, we determined that eukaryotic translation initiation factor 2 alpha kinase 2 (eIF2AK2) bridged YTHDF3 and eIF3A, enhancing the stability of the YTHDF3/eIF3A complex in OXAR CRC cells. Taken together, our data identified YTHDF3 as a novel hallmark and revealed the molecular mechanism of YTHDF3 on gene translation via coordination with eIF2AK2 in OXAR CRC cells.
Insights
YTHDF3 is highly expressed in oxaliplatin-resistant colorectal cancer (CRC). It enhances gene translation by coordinating with eIF2AK2, offering a new target for overcoming chemo-resistance.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Oxaliplatin is a key first-line chemotherapy for colorectal cancer (CRC).
- Chemo-resistance to oxaliplatin is a significant challenge in CRC treatment.
- N6-methyladenosine (m6A) RNA modification plays roles in various cellular functions, but its role in CRC chemo-resistance is unclear.
Purpose of the Study:
- To investigate the role of m6A RNA-binding protein YTHDF3 in oxaliplatin resistance in CRC.
- To elucidate the molecular mechanism by which YTHDF3 influences gene translation in chemo-resistant CRC cells.
Main Methods:
- Analysis of YTHDF3 expression in oxaliplatin-resistant (OXAR) CRC tissues and cells.
- Investigation of YTHDF3's interaction with m6A-modified RNAs and eukaryotic translation initiation factor 3 subunit A (eIF3A).
- Determination of the role of eukaryotic translation initiation factor 2 alpha kinase 2 (eIF2AK2) in the YTHDF3/eIF3A complex stability.
Main Results:
- YTHDF3 expression is elevated in OXAR CRC tissues and cells.
- YTHDF3 binds to m6A-modified RNAs in their 5' untranslated region, promoting the translation of resistance-associated genes.
- eIF2AK2 acts as a bridge between YTHDF3 and eIF3A, stabilizing their complex and enhancing translation in OXAR CRC cells.
Conclusions:
- YTHDF3 is identified as a novel hallmark of oxaliplatin resistance in CRC.
- A molecular mechanism involving YTHDF3, eIF2AK2, and eIF3A in regulating gene translation and promoting chemo-resistance is revealed.
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Improving Translational Accuracy
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of the Unfolded Protein Response

